dc.contributor.author | Uzun, Hafize | |
dc.contributor.author | Dikmen, Göksel | |
dc.contributor.author | Aytac, Erman | |
dc.contributor.author | Altug, Tuncay | |
dc.contributor.author | Seymen, Hakkı Oktay | |
dc.date.accessioned | 2021-03-06T10:46:58Z | |
dc.date.available | 2021-03-06T10:46:58Z | |
dc.date.issued | 2006 | |
dc.identifier.citation | Aytac E., Seymen H. O. , Uzun H., Dikmen G., Altug T., "Effects of iloprost on visual evoked potentials and brain tissue oxidative stress after bilateral common carotid artery occlusion", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, cilt.74, ss.373-378, 2006 | |
dc.identifier.issn | 0952-3278 | |
dc.identifier.other | av_ec014cd8-53b1-4e31-bab7-918462db450b | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/154965 | |
dc.identifier.uri | https://doi.org/10.1016/j.plefa.2006.03.006 | |
dc.description.abstract | Effects of iloprost on visual evoked potentials and oxidant/antioxidant status were evaluated after bilateral carotid artery occlusion. There were three experimental groups; Sham (S) group (n = 10), bilateral common carotid artery occluded (BCCAO) group (n = 10) and after bilateral common carotid artery occlusion, iloprost-treated (BCCAOI) group (n = 10). Iloprost was administered (0.5 ng/kg/day) for 10 days by intraperitoneal injection. N-2 and P-2 latencies (millisecond) and N-2-P-2 (PV) amplitudes were recorded 10 days after operation for evaluating VEPs. The rats were sacrificed by decapitation immediately after recording of VEPs. Malondialdehyte (MDA), glutathione (GSH), Cu-Zn superoxide dysmutase (SOD) were studied spectrophotometriely. After BCCAO, MDA levels were increased, GSH and Cu-Zn SOD levels were decreased significantly, and abnormal VEPs parameters were observed. Iloprost treatment after BCCAO decreased MDA and increased GSH levels significantly. Low Cu-Zn SOD levels and impaired VEPs remained after iloprost treatment. Iloprost treatment may protect the brain tissue from oxidative damage during cerebral hypoperfusion. (c) 2006 Elsevier Ltd. All rights reserved. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Histoloji-Embriyoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Sitogenetik | |
dc.subject | Temel Bilimler | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.subject | HÜCRE BİYOLOJİSİ | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.title | Effects of iloprost on visual evoked potentials and brain tissue oxidative stress after bilateral common carotid artery occlusion | |
dc.type | Makale | |
dc.relation.journal | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 74 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 373 | |
dc.identifier.endpage | 378 | |
dc.contributor.firstauthorID | 18690 | |